In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines

In Vitro Cellular and Developmental Biology - Animal

Volumn 52, Issue 2, 2016, Pages 163-173

  Deepak, Venkataraman ^a,b   Ramachandran, Sharavan ^b   Balahmar, Reham Mohammed ^b   Pandian, Sureshbabu Ram Kumar ^a   Sivasubramaniam, Shiva D ^b   Nellaiah, Hariharan ^a   Sundar, Krishnan ^a  

^a KALASALINGAM UNIVERSITY   (India)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

Antioxidative; Colon cancer; Exopolysaccharides; L. acidophilus; RT qPCR

Indexed keywords

BACTERIAL POLYSACCHARIDE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; HEME OXYGENASE 1; HIF1A PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR PROTEIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

BIOSYNTHESIS; CACO-2 CELL LINE; CELL HYPOXIA; CHEMISTRY; COLONIC NEOPLASMS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LACTOBACILLUS ACIDOPHILUS; PATHOLOGY;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CACO-2 CELLS; CELL HYPOXIA; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEME OXYGENASE-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LACTOBACILLUS ACIDOPHILUS; NEOPLASM PROTEINS; POLYSACCHARIDES, BACTERIAL; TISSUE INHIBITOR OF METALLOPROTEINASE-3; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84958119742     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-015-9970-3     Document Type: Article

References (55)

1. Aachary AA, Gobinath D, Srinivasan K, Prapulla SG (2015) Protective effect of xylooligosaccharide from corncob on 1,2-dimethylhydrazine induced colon cancer in rats. Bioact Carbohydr Dietary Fibre 5:146–152
2. Alfadda AA, Sallam RM (2012) Reactive oxygen species in health and disease. J Biomed Biotechnol. doi:10.1155/2012/936486
3. Anderson JW, Gilliland SE (1999) Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 18:43–50
4. Arora DS, Chandra P (2011) In vitro antioxidant potential of some soil fungi: screening of functional compounds and their purification from Penicillium citrinum. Appl Biochem Biotechnol 165(2):639–651
5. Badel S, Bernardi T, Michaud P (2011) New perspectives for Lactobacilli exopolysaccharides. Biotechnol Adv 29(1):54–66
6. Baker AH, George SJ, Zaltsman AB, Murphy G, Newby AC (1999) Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by over expression of TIMP-3. Br J Cancer 79(9–10):1347–1355
7. Bansal S, Biswas G, Avadhani NG (2014) Mitochondria-targeted heme oxygenase-1 induces oxidative stress and mitochondrial dysfunction in macrophages, kidney fibroblasts and in chronic alcohol hepatotoxicity. Redox Biol 2:273–283
8. Becker JC, Fukui H, Imai Y, Sekikawa A, Kimura T, Yamagishi H, Yoshitake N, Pohle T, Domschke W, Fujimori T (2007) Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer. Scand J Gastroenterol 42(7):852–858
9. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung H, Colburn NH, Sun Y (1996) Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17(9):1805–1811
10. Bolte S, Talbot C, Boutte Y, Catrice O, Read ND, Satiat‐Jeunemaitre B (2004) FM‐dyes as experimental probes for dissecting vesicle trafficking in living plant cells. J Microsc 214(2):159–173
11. Brahimi-Horn MC, Chiche J, Pouysségur J (2007) Hypoxia and cancer. J Mol Med 85(12):1301–1307
12. Chan AT, Giovannucci EL (2010) Primary prevention of colorectal cancer. Gastroenterology 138(6):2029–2043
13. Choi SS, Kim Y, Han KS, You S, Oh S, Kim SH (2006) Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett App Microbiol 42(5):452–458
14. Clarke G, Ting KN, Wiart C, Fry J (2013) High correlation of 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, ferric reducing activity potential and total phenolics content indicates redundancy in use of all three assays to screen for antioxidant activity of extracts of plants from the malaysian rainforest. Antioxidants 2(1):1–10
15. Contreras MF, Sougrat R, Zaher A, Ravasi T, Kosel J (2015) Non-chemotoxic induction of cancer cell death using magnetic nanowires. Int J Nanomed 10:2141–2153
16. Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, Bunz F, Kantsevoy SV, Dang LH (2006) Hypoxia-inducible factor-1α promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66(3):1684–1693
17. Deepak V, Ramachandran S, Pandian SRK, Sivasubramaniam SD, Nellaiah H, Sundar K (2014) Exopolysaccharides from L. acidophilus for Colon Cancer Treatment. Proceedings of International conference on beneficial microbes- ICOBM2014, 116–119.
18. Deepak V, Pandian SRK, Sivasubramaniam SD, Nellaiah H, Sundar K (2015) Optimization of anticancer exopolysaccharide production from probiotic Lactobacillus acidophilus by response surface methodology. Prep Biochem Biotechnol. doi:10.1080/10826068.2015.1031386
19. Deraz S, Karlsson NE, Khalil AA, Mattiasson B (2007) Mode of action of acidocin D20079, a bacteriocin produced by the potential probiotic strain, Lactobacillus acidophilus DSM 20079. J Ind Microbiol Biotechnol 34:373–379
20. Destouches D, Huet E, Sader M, Frechault S, Carpentier G, Ayoul F, Briand JP, Menashi S, Courty J (2012) Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release. J Biol Chem 287(52):43685–43693
21. Dkhissi F, Lu H, Soria C, Opolon P, Griscelli F, Liu H, Khattar P, Mishal Z, Perricaudet M, Li H (2003) Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells. Hum Gene Ther 14(10):997–1008
22. Ellis LM, Takahashi Y, Liu W, Shaheen RM (2000) Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 5(Suppl 1):11–15
23. Ferrara N (2005) VEGF as a therapeutic target in cancer. Oncology 69(Suppl 3):11–16
24. Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Disc 3(5):391–400
25. Folkman J (2006) Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res 312(5):594–607
26. Gasparotto J, Somensi N, Kunzler A, Girardi CS, de Bittencourt Pasquali MA, Ramos VM, Simoes-Pires A, Quintans-Junior LJ, Branco A, Moreira JC, Gelain DP (2014) Hecogenin acetate inhibits reactive oxygen species production and induces cell cycle arrest and senescence in the A549 human lung cancer cell line. Anticancer Agents Med Chem 14(8):1128–1135
27. Han PP, Sun Y, Wu XY, Yuan YJ, Dai YJ, Jia SR (2014) Emulsifying, flocculating, and physicochemical properties of exopolysaccharide produced by cyanobacterium Nostoc flagelliforme. Appl Biochem Biotechnol 172(1):36–49
28. Holzapfel WH, Haberer P, Snel J, Schillinger U, Veld JH (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41:85–101
29. Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z (2010) Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci 107(16):7455–7460
30. Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, Mino‐Kenduson M, Lynch MP, Rueda BR, Benita Y, Xavier RJ, Chung DC (2009) HIF‐1α and HIF‐2α have divergent roles in colon cancer. Int J Cancer 124(4):763–771
31. Kallio JP, Hopkins‐Donaldson S, Baker AH, Kähäri VM (2011) TIMP‐3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathway. Int J Cancer 128(4):991–996
32. Li L, Lin X, Staver M, Shoemaker A, Semizarov D, Fesik SW, Shen Y (2005) Evaluating hypoxia-inducible factor-1α as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res 65(16):7249–7258
33. Li S, Zhao Y, Zhang L, Zhang X, Huang L, Li D, Li D, Niu C, Yang Z, Wang Q (2002) Antioxidant activity of Lactobacillus plantarum strains isolated from traditional Chinese fermented foods. Food Chem 135(3):1914–1919
34. Liu CF, Tseng KC, Chiang SS, Lee BH, Hsu WH, Pan TM (2011a) Immunomodulatory and antioxidant potential of Lactobacillus exopolysaccharides. J Sci Food Agric 91(12):2284–2291
35. Liu CT, Chu FJ, Chou CC, Yu RC (2011b) Antiproliferative and anticytotoxic effects of cell fractions and exopolysaccharides from Lactobacillus casei 01. Mutat Res Genet Toxicol Environ Mutagen 721(2):157–162
36. Liu B, Xu Y, Voss C, Qiu FH, Zhao MZ, Liu YD, Nie J, Wang ZL (2012) Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathways. PLoS One 7(9), e44701
37. Mohandas KM, Desai DC (1999) Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol 18(3):118–121
38. Nielsen HJ, Pappot H, Christensen IJ, Brünner N, Thorlacius-Ussing O, Moesgaard F, Danø K, Grøndahl-Hansen J (1998) Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer. BMJ 316(7134):829–830
39. Pachner M, Su K, Grant P (2014) High-frequency stimulus and high-K+ solution cause kiss-and-run fusion at the crayfish neuromuscular junction. Pioneering Neurosci J 14:69–72
40. Pan D, Mei X (2010) Antioxidant activity of an exopolysaccharide purified from Lactococcus lactis subsp. lactis 12. Carbohyd Polym 80(3):908–914
41. Qi JH, Anand-Apte B (2015) Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism. Apoptosis 20(4):523–534
42. Reid TM, Feig DI, Loeb LA (1994) Mutagenesis by metal-induced oxygen radicals. Environ Health Perspect 102(Suppl 3):57–61
43. Ryter SW, Tyrrell RM (2000) The heme synthesis and degradation pathways: role in oxidant sensitivity: heme oxygenase has both pro-and antioxidant properties. Free Radical Biol Med 28(2):289–309
44. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A (2005) Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. Br J Cancer 93(7):799–803
45. Semenza GL (2010) HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20(1):51–56
46. Suzuki J, Nagata S (2014) Phospholipid scrambling on the plasma membrane. Methods Enzymol 544:381–393
47. Tappel A (2007) Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases. Med Hypotheses 68(3):562–564
48. Thevenot P, Cho J, Wavhal, D, Timmons RB, Tang L (2008) Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomed Nanotechnol Biol Med 4(3):226–236
49. Trédan O, Galmarini CM, Patel K, Tannock IF (2007) Drug resistance and the solid tumor microenvironment. J Nat Cancer I 99(19):1441–1454
50. 2A receptors. Vasc Pharm 55(5):157–162
51. Valko M, Rhodes CJ, Moncol J, Izakovic MM, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160(1):1–40
52. Wang K, Li W, Rui X, Chen X, Jiang M, Dong M (2014) Characterization of a novel exopolysaccharide with antitumor activity from Lactobacillus plantarum 70810. Int J Biol Macromol 63:133–139
53. Wollowski I, Rechkemmer G, Pool-Zobel BL (2001) Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73:451S–455S
54. Zhang L, Liu C, Li D, Zhao Y, Zhang X, Zeng X, Yang Z, Li S (2013) Antioxidant activity of an exopolysaccharide isolated from Lactobacillus plantarum C88. Int J Biol Macromol 54:270–275
55. Zong A, Cao H, Wang F (2012) Anticancer polysaccharides from natural resources: a review of recent research. Carbohyd Polym 90(4):1395–1410